No Data
No Data
Double Medical Technology Inc. (002901.SZ): has cumulatively repurchased 0.31% of shares.
On January 3, Glonghui announced that Double Medical Technology Inc. (002901.SZ) reported that as of December 31, 2024, the company had repurchased a total of 1,263,000 shares through a dedicated repurchase securities account via centralized bidding, accounting for 0.3051% of the company's total equity, with the highest Fill Price at 35.00 yuan/share, the lowest Fill Price at 31.76 yuan/share, and a total amount of 42.0856 million yuan (excluding trading fees).
Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly
Double Medical Technology Inc. (002901.SZ): Received a total of 11.9 million yuan in government subsidies.
On December 9th, Gelonghui reported that double medical technology inc. (002901.SZ) announced that the company and its controlling subsidiaries, Shiaid Medical Equipment Co., Ltd. (Xiamen), Baichitai Medical Technology Co., Ltd. (Xiamen), and Saco Medical Technology Co., Ltd. (Xiamen), recently received government subsidies totaling 11.9 million yuan, accounting for 20.18% of the audited net income attributable to shareholders of the listed company in the most recent fiscal year.
Double Medical Technology (SZSE:002901) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Dabo Healthcare: Report for the third quarter of 2024
Double Medical Technology Inc. (002901.SZ): net income of 0.24 billion yuan in the first three quarters, a year-on-year increase of 145.48%.
Double Medical Technology Inc. (002901.SZ) announced its third quarter report for 2024 on October 30th. The company achieved revenue of 1.529 billion yuan in the first three quarters, a year-on-year increase of 35.88%; net income attributable to shareholders of the listed company was 0.24 billion yuan, a year-on-year increase of 145.48%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.211 billion yuan, a year-on-year increase of 297.20%; basic earnings per share were 0.5794 yuan.